Skip to main content
. 2012 May;60(6B):E12–E18. doi: 10.1111/j.1365-2559.2012.04174.x

Figure 3.

Figure 3

Kaplan–Meier survival curves of patients with stage I testicular germ cell tumours (TGCTs). The relapse-free survival rate of patients with seminomas showing focal DNMT3B expression (red solid line) was significantly lower than that of patients with seminomas not showing this feature (red broken line, P = 0.0464). There was no significant difference between the relapse-free survival rate of patients with seminomas showing focal DNMT3B expression and that of patients with non-seminomatous TGCTs (gray line, P = 0.747). The time to relapse of patients with seminomas showing DNMT3B expression tended to be longer than that of patients with non-seminomatous TGCTs.